Dr. Shiyu Cheng was named to the 2025 Forbes China New Era Disruptive Founder Selection.

Recently, Forbes China and the Globalization Institute of Business Studies released the final results of the "2025 Forbes China New Era Disruptive Founder Selection," with Dr. Cheng Shiyu, founder of RouMai Medical (Shenzhen) Co., Ltd., being selected.

The "2025 Forbes China New Era Disruptive Founder Selection" was launched by Forbes China, focusing on cutting-edge technology and industrial restructuring trends. It is open to disruptive leaders in fields such as technology and business. The selection process established clear basic criteria and compliance requirements for candidates and their enterprises, with rigorous evaluation conducted across dimensions such as "business achievements, industry contributions, disruptive power, innovation capability, and social responsibility." In announcing the results, the selection emphasized attention to the industrial depth of technology implementation and the intrinsic commercial value, aiming to illustrate the shift in China's industrial core drivers and the landscape of future value creation.

RouMai Medical has long addressed critical clinical needs, including cardiovascular and cerebrovascular diseases. It has persistently tackled key technologies in tissue engineering and regenerative medicine, driving innovative achievements toward a path of verifiable, replicable, and scalable product development. Moving forward, RouMai Medical will continue to prioritize clinical value, steadily advance the refinement of its key technology systems and industrial capabilities, deepen collaborative innovation with clinical institutions, research institutes, and industry partners, and accelerate the transformation of achievements and the process of international development.

Zhanbing Ren

President of EPFL Alumni China